Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
The Lancet. Oncology|June 2, 2016
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trialTanguy Y Seiwert, Barbara Burtness, Ranee Mehra, et al.
Anticancer Research|September 15, 2019
Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant TherapyGokoulakrichenane Loganadane, Benjamin H Kann, Henry S Park, et al.
Oncogene|January 17, 2019
APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinomaVincent L Cannataro, Stephen G Gaffney, Tomoaki Sasaki, et al.
Cancers|July 9, 2020
Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell CarcinomaStefan P Haider, Tal Zeevi, Philipp Baumeister, et al.
Future Oncology (London, England)|January 30, 2026
JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCCLillian L Siu, Barbara Burtness, Kevin Harrington, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 14, 2020
PET/CT radiomics signature of human papilloma virus association in oropharyngeal squamous cell carcinomaStefan P Haider, Amit Mahajan, Tal Zeevi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2010
Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancerKyle E Rusthoven, Steven J Feigenberg, David Raben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2015
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell CarcinomaThomas J Galloway, Lori J Wirth, Alexander D Colevas, et al.
The Breast Journal|November 18, 2003
Sequential high-dose alkylating therapy and stem cell support for high-risk stage III breast cancerJosette Bou-Khalil, Michal Rose, Amanda Psyrri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of <i>ERCC1</i>: SWOG S1201Syma Iqbal, Shannon McDonough, Heinz-Josef Lenz, et al.
Pageof 16